LMT Investor Update: Securities Lawsuit Hits Lockheed Martin (LMT) Over Program Losses — Hagens Berman

(NYSE:LMT), SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit has been filed against Lockheed Martin Corporation (NYSE: LMT) on behalf of investors who purchased shares between January 23, 2024, and July 21, 2025. The lawsuit, captioned Khan v. Lockheed Martin Corporation, alleges that the company misled investors about the financial […]

Predicine Submits First Module of PMA Application to FDA for PredicineCARE(TM) as a Companion Diagnostic Assay in Bladder Cancer

HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) — Predicine, Inc., a leading molecular insights company, today announced the submission of the first module of its premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for PredicineCARE(TM) urine cfDNA NGS assay, as a companion diagnostic (CDx) for patients with bladder cancer. The first

Investors Sue SelectQuote (SLQT) After DOJ Intervenes in Kickback Lawsuit – Hagens Berman

Investors Sue SelectQuote (SLQT) After DOJ Intervenes in Kickback Lawsuit – Hagens Berman SLQT Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire September 02, 2025 SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) — A new securities class-action lawsuit has been filed against SelectQuote, Inc. (NYSE: SLQT) and its executives after the U.S. Department of

LMT Investor Update: Securities Lawsuit Hits Lockheed Martin (LMT) Over Program Losses — Hagens Berman

LMT Investor Update: Securities Lawsuit Hits Lockheed Martin (LMT) Over Program Losses — Hagens Berman LMT Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire September 02, 2025 SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit has been filed against Lockheed Martin Corporation (NYSE: LMT) on behalf of investors who

Predicine Submits First Module of PMA Application to FDA for PredicineCARE(TM) as a Companion Diagnostic Assay in Bladder Cancer

Predicine Submits First Module of PMA Application to FDA for PredicineCARE(TM) as a Companion Diagnostic Assay in Bladder Cancer GlobeNewswire September 02, 2025 HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) — Predicine, Inc., a leading molecular insights company, today announced the submission of the first module of its premarket approval (PMA) application to the U.S.

Kallpa Generacion S.A. Announces the Commencement of a Cash Tender Offer for any and all of its 4.125% Senior Notes due 2027

LIMA, Peru, Sept. 02, 2025 (GLOBE NEWSWIRE) — Kallpa Generacion S.A., a sociedad anonima incorporated under the laws of Peru (the “Company“) today announced that it has commenced a cash tender offer (the “Offer“) for any and all of its outstanding 4.125% Senior Notes due 2027 (the “Notes“). The Offer is subject to certain conditions,

Kallpa Generacion S.A. Announces the Commencement of a Cash Tender Offer for any and all of its 4.125% Senior Notes due 2027

Kallpa Generacion S.A. Announces the Commencement of a Cash Tender Offer for any and all of its 4.125% Senior Notes due 2027 GlobeNewswire September 02, 2025 LIMA, Peru, Sept. 02, 2025 (GLOBE NEWSWIRE) — Kallpa Generacion S.A., a sociedad anonima incorporated under the laws of Peru (the “Company“) today announced that it has commenced a

Medical Horizons and Bowhead Health Inc. Announce Exclusive Partnership to Bring AI-Powered Clinical Research Solutions to Italy, Turkey, and Cyprus

Medical Horizons S.r.l., (medicalhorizons.it) a leading distributor of Artificial Intelligence (AI) solutions for healthcare, today announced an exclusive distribution agreement with Bowhead Health Inc.(bowheadhealth.com), a Canadian innovator in secure health data management and AI-powered clinical trial matching. Under this agreement, Medical Horizons becomes the exclusive partner for Bowhead Health in Italy, Turkey, and Cyprus, expanding

Matador Network Launches ‘Matador House’ Creator Residency in Myrtle Beach

Eight talented creators have arrived in South Carolina ready to unlock their creativity and step over the threshold into “Matador House: Creators in Residency Myrtle Beach.” This first-of-its-kind, monthlong creator residency is a production of Matador Network, the world's No. 1 media brand for modern adventurers, in partnership with Visit Myrtle Beach, the official destination

US Navy Awards ANELLO Photonics Contract Phase II Option SBIR Topic “N234-P02: NAVAIR Open Topic for Logistics in a Contested Environment”

ANELLO was selected for a Small Business Innovation Research Phase II due to its innovative optical gyroscope technology and its unique sensor fusion engine following their selection as an “N234-P02: NAVAIR Open Topic for Logistics in a Contested Environment” and successfully completing their Phase I Option SBIR for the U.S. Navy. ANELLO Photonics, the creator

Scroll to Top